{"lc": {"ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds": {"story_link": "https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "user_code": "GOLD_25", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-27 12:35:9", "close_timestamp": 1638016509350, "created": "27/11/2021 12:35:08", "department": "Institute of Management ", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-27", "gender": "female", "id": "f5dbbfde-3cb8-4d9b-8ea1-ab619dad9f54", "open_date_time": "2021-10-27 12:30:40", "open_timestamp": 1638016240935, "story_date": "2020-04-21 00:00:00", "story_source": "tpl", "story_title": "Ivermectin can kill COVID-19 within 48 hours', Monash University study finds", "summary": "A collaborative partnership between BDI and the Doherty Institute has taken place to study the effectiveness of a known drug, shown to have anti-parasitic abilities.\r\n", "task_condition": "text", "task_key": "ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "task_level": "under_graduate_year_3", "time_taken_in_seconds": 268415, "what": "Study on Ivermectin efficacy ", "when_happened": "few_years_ago", "where_location": "Malborne ", "who": "Ivermectin, Monash University", "why": "reduces cases of covid and deal with Covid crisis "}, "challenges-expected-for-novavax-covid-19-vaccine-in-usa": {"story_link": "https://www.thepharmaletter.com/article/challenges-expected-for-novavax-covid-19-vaccine-in-usa", "user_code": "GOLD_25", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-27 12:26:28", "close_timestamp": 1638015988728, "created": "27/11/2021 12:26:28", "department": "Institute of Management ", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-27", "gender": "female", "id": "98e301d7-9aca-479d-a2f7-b1d387d52177", "open_date_time": "2021-10-27 12:24:31", "open_timestamp": 1638015871502, "story_date": "2021-06-23 00:00:00", "story_source": "tpl", "story_title": "Challenges expected for Novavax' COVID-19 vaccine in USA", "summary": "The story highlights the main challenges the US government is facing when using the Novavax' COVID-19 vaccine.", "task_condition": "viz", "task_key": "challenges-expected-for-novavax-covid-19-vaccine-in-usa", "task_level": "under_graduate_year_3", "time_taken_in_seconds": 117226, "what": "Novavax' COVID-19 vaccine", "when_happened": "current_month", "where_location": "Challenges expected for Novavax' COVID-19 vaccine", "who": "Novavax, USA", "why": "Tackling the covid pandemic"}, "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19": {"story_link": "https://www.thepharmaletter.com/article/australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "user_code": "GOLD_25", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-27 12:24:18", "close_timestamp": 1638015858135, "created": "27/11/2021 12:24:19", "department": "Institute of Management ", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-27", "gender": "female", "id": "9a1c96a8-f054-4187-993e-524d6d91d067", "open_date_time": "2021-10-27 12:20:24", "open_timestamp": 1638015624522, "story_date": "2020-08-20 00:00:00", "story_source": "tpl", "story_title": "Australian GPs urged to prescribe ivermectin triple therapy to fight COVID-19", "summary": "The story is on Australian GPs and the need to use a specific vaccine to solve the COVID crisis by prescribing triple vaccine therapy. ", "task_condition": "viz", "task_key": "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "task_level": "under_graduate_year_3", "time_taken_in_seconds": 233613, "what": "Australia GPs", "when_happened": "few_years_ago", "where_location": "Australia ", "who": "Australia ", "why": "Health related to COVID pandemic"}, "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve": {"story_link": "https://www.thepharmaletter.com/article/japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "user_code": "GOLD_25", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-27 12:30:23", "close_timestamp": 1638016223980, "created": "27/11/2021 12:30:23", "department": "Institute of Management ", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-27", "gender": "female", "id": "206c7251-b876-414a-8bf7-853b74eb9f7e", "open_date_time": "2021-10-27 12:26:35", "open_timestamp": 1638015995900, "story_date": "2020-07-21 00:00:00", "story_source": "tpl", "story_title": "Japan is first country to approve COVID-19 cocktail Ronapreve", "summary": "Major Swiss Pharma company Roche has successfully gained approval from Japan's Ministry of Health and Labor the Ronapreve vaccine as part of its treatment for COVID-19 via intravenous infusion.\r\n\r\n", "task_condition": "text", "task_key": "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "task_level": "under_graduate_year_3", "time_taken_in_seconds": 228080, "what": "Approval of Ronapreve vaccine by Swiss Pharma giant. ", "when_happened": "few_years_ago", "where_location": "Japan", "who": "Japan,Ronapreve", "why": "Tackling the Covid crisis "}}, "tb": {"pfizer": {"story_term": "pfizer", "user_code": "GOLD_25", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-27 12:50:23", "close_timestamp": 1638017423474, "created": "27/11/2021 12:50:24", "department": "Institute of Management ", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-27", "gender": "female", "id": "2112364d-c5d5-470b-92d9-88d6f55ff1fa", "open_date_time": "2021-10-27 12:44:7", "open_timestamp": 1638017047462, "summary": "FDA approval of Myfembree has led to a significant milestone being reached for heavy menstrual bleeding associated with uterine fibroids. \r\nIt see's the approval of a second FDA approved drug this year and expanding non invasive treatment options for women suffering from uterine fibroids. \r\nDavid Marek (CEO of Myrant) had this to say: \u00e2\u0080\u009cUterine fibroids affect millions of women in the USA and account for over 250,000 hysterectomies each year, with heavy menstrual bleeding being one of the most bothersome symptoms.\r\nThis indicates the vast progress made in between Myovant and Pfizer who will jointly commercialize the product in the USA, to help treat millions of women.", "task_condition": "text", "task_key": "pfizer", "task_level": "under_graduate_year_3", "time_taken_in_seconds": 376012}, "astrazeneca": {"story_term": "astrazeneca", "user_code": "GOLD_25", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-27 12:43:51", "close_timestamp": 1638017031216, "created": "27/11/2021 12:43:52", "department": "Institute of Management ", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-27", "gender": "female", "id": "3fe4998a-dde4-41c9-a18c-0bac738aeb84", "open_date_time": "2021-10-27 12:35:16", "open_timestamp": 1638016516013, "summary": "As the world fights the ongoing COVID crisis, a major provider AstraZeneca (AZN) is being taken to court by  the Belgian courts because it failed to fufill its contractual obligations in providing enough vaccine supplies. \r\n\r\nEU leaders are frustrated by the low roll out and delays to supply and demand are causing deaths to rise and effective monitoring to be delayed. \r\nThis is not the case for other EU countries like the UK who have successfully rolled out the AZN vaccine. Hence officials are threatening to block vaccine exports in Febraruary because of \"vaccine nationalism\" concerns. \r\n\r\nEU council has said AZN should divert UK supplies from the UK to the EU under contractual agreements. \r\n\r\n", "task_condition": "viz", "task_key": "astrazeneca", "task_level": "under_graduate_year_3", "time_taken_in_seconds": 515203}}}